Therapeutic potential of human embryonic stem cells in type 2 diabetes mellitus

Table 1 Number and percentage of patients who scored less than the highest possible grade at baseline and reached highest possible grade at the end of T1 (n = 95)

Parameter	< HPG (n) at baseline	HPG n (%) at T1
FBS	95	61 (64.2)
HbA1c	93	44 (47.3)
Insulin level	91	60 (65.9)
Insulin with medication	92	24 (26.1)
Medication level	93	25 (26.9)
Post-prandial blood insulin 60 min	95	58 (61.1)
Post-prandial blood sugar	95	58 (61.1)
Pre-dinner	95	55 (57.9)
Secondary complication	84	27 (32.1)
Serum insulin	94	74 (78.7)
Serum peptide	90	65 (72.2)

HbA1c: Glycated hemoglobin; FBS: Fasting blood sugar; < HPG: Less than the highest possible grade.

Table 2 Number and percentage of patients who showed improvement by at least one grade of Nutech functional score at baseline to the end of T1 (n = 95)

Parameter	Patients (n) affected at baseline	Improved n (%)
FBS	95	93 (97.9)
HbA1c	93	90 (96.8)
Insulin level	91	88 (96.7)
Insulin with medication	92	88 (95.7)
Medication level	93	82 (88.2)
Post-prandial blood insulin 60 min	95	92 (96.8)
Post-prandial blood sugar	95	92 (96.8)
Pre-dinner	95	93 (97.9)
Secondary complication	84	79 (94.0)
Serum insulin	94	80 (85.1)
Serum peptide	90	87 (96.7)

HbA1c: Glycated hemoglobin; FBS: Fasting blood sugar.